Protein Design and Engineering in Biopharma Summit

Memo

Advances in protein language models, generative design, structural biology, high-throughput experimentation and protein analytics are rapidly expanding the possibilities of therapeutic protein engineering. Yet as designed proteins move from computational promise toward clinical reality, the challenge is no longer simply generating protein candidates, but understanding which molecules possess the stability, functionality, developability and manufacturability required for successful therapeutic translation, at scale. The inaugural Protein Design and Engineering in Biopharma Summit arrives, bringing together 80+ carefully selected leaders across protein engineering, structural biology, computational biology, biophysics, developability and biologics R AND D. Unlike broader AI, biologics or drug discovery meetings, this highly technical and industry-focused forum provides a rare opportunity to examine the entire Design-Build-Test-Learn cycle, from rational and de novo design through experimental validation, protein characterization, optimization and translational development. Through practical case studies and peer-led discussion, attendees will benchmark integrated computational and wet-lab workflows, explore strategies to improve design predictability, and accelerate iteration cycles across antibodies, enzymes, mini-proteins, vaccines and next-generation biologics. Join the scientists defining the future of therapeutic protein engineering and leave with actionable insights, meaningful collaborations and proven approaches to translate better protein designs into successful therapeutics. URLs:Tickets: https://go.evvnt.com/3757097-2?pid=5569 Brochure: https://go.evvnt.com/3757097-3?pid=5569  Date and Time: Tue, 10 Nov 2026 08:00 - Thu, 12 Nov 2026 15:50 Venue details: Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, Massachusetts, 02114, United States  Prices:Pharma and Biotech Pricing - 3 Day Pass - (Conference + 2 Workshops): USD 4397.00,Pharma and Biotech Pricing - 3 Day Pass - (Conference + 1 Workshop): USD 3748.00,Pharma and Biotech Pricing - 2 Day Pass - (Conference Only): USD 3099.00,Academic Pricing - 3 Day Pass - (Conference + 2 Workshops): USD 3797.00,Academic Pricing - 3 Day Pass - (Conference + 1 Workshop): USD 3248.00,Academic Pricing - 2 Day Pass - (Conference Only): USD 2699.00,Service Provider Pricing - 3 Day Pass - (Conference + 2 Workshops): USD 5297.00,Service Provider Pricing - 3 Day Pass - (Conference + 1 Workshop): USD 4548.00,Service Provider Pricing - 2 Day Pass - (Conference Only): USD 3799.00   Speakers: Rajeeva Singh, Senior Principal Research Scientist, Biologics Drug Product Development, AbbVie, Ben Meinen, Head, Protein Design and Investigator, AI Proteins, Vanina Chiarpotti, Computational Investigator, AI Proteins, James Bowman, Chief Technology Officer, AI Proteins, Bhupal Ban, Director, Antibody Discovery, Protein Engineering and Development, Crossbow Therapeutics, Lauren Ely, Senior Director, Lead Discovery and Protein Engineering, CSL, Jason Lajoie, Director, Protein Engineering, Deck Bio, Melissa Geddie, Senior Vice President, Drug Discovery, Diagonal Therapeutics, Vladimir Voynov, Head, Discovery Biologics, Fable Therapeutics, Ye Che, Senior Director, Global Head of Protein Structure and Biochemistry, GSK, Stephen Harper, Senior Director, In Silico Biologics, Immunocore, Ertan Eryilmaz, Vice President, Biologics, InduPro, Ronnie Wei, Vice President, Biologics Discovery and Development, ModeX Therapeutics, Qiang Yang, Director, Protein Engineering and Conjugation, OncoC4, Karen Conrad, Scientific Associate Director, Protein Science, Structural Biology, Takeda, Yao Fan, Director, Protein Design and Optimization, Tectonic Therapeutic, Ning Li, Vice President, Discovery, Versatope Therapeutics, Alex Nisthal, Director, Protein Engineering, Xencor